ロード中...

Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures

In early stage non-small cell lung cancer (NSCLC) large randomized trials have demonstrated that in patients with radically resected disease adjuvant chemotherapy improves 5-year survival rates. However, a customization of systemic treatment is needed to avoid treatments in patients cured by surgery...

詳細記述

保存先:
書誌詳細
出版年:Transl Lung Cancer Res
主要な著者: Carnio, Simona, Novello, Silvia, Papotti, Mauro, Loiacono, Marco, Scagliotti, Giorgio Vittorio
フォーマット: Artigo
言語:Inglês
出版事項: Pioneer Bioscience Publishing Company 2013
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367732/
https://ncbi.nlm.nih.gov/pubmed/25806256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.10.05
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!